Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $2.2M | 1% | Sep 2025 |
|
| Millennium Management | 625k | $1000k | -6% | Sep 2025 |
|
| Acadian Asset Management | 490k | $782k | 0% | Sep 2025 |
|
| BlackRock | 364k | $582k | -22% | Sep 2025 |
|
| Geode Capital Management | 328k | $526k | 0% | Sep 2025 |
|
| Renaissance Technologies | 289k | $462k | 38% | Sep 2025 |
|
| Two Sigma Investments | 234k | $375k | 403% | Sep 2025 |
|
| Gagnon Securities | 226k | $362k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 196k | $314k | 100% | Sep 2025 |
|
| Citadel Advisors | 152k | $243k | 61% | Sep 2025 |
|
| State Street Corporation | 126k | $202k | -43% | Sep 2025 |
|
| Susquehanna International | 123k | $196k | 48% | Sep 2025 |
|
| Gen-Wealth Partners | 109k | $175k | 100% | Sep 2025 |
|
| Jane Street | 93k | $149k | -57% | Sep 2025 |
|
| Morgan Stanley | 45k | $63k | 100% | Jun 2025 |
|
| Bridgeway Capital Management | 40k | $64k | 0% | Sep 2025 |
|
| Northern Trust | 36k | $57k | -40% | Sep 2025 |
|
| Dimensional Fund Advisors | 35k | $56k | 0% | Sep 2025 |
|
| Vontobel Holding | 30k | $48k | 0% | Sep 2025 |
|
| Marshall Wace | 26k | $42k | -73% | Sep 2025 |
|
| Qube Research & Technologies | 26k | $41k | -48% | Sep 2025 |
|
| Callan Family Office | 24k | $38k | 0% | Sep 2025 |
|
| Mayport | 22k | $35k | 100% | Sep 2025 |
|
| FMR | 21k | $34k | -13% | Sep 2025 |
|
| North Star Asset Management | 20k | $32k | 0% | Sep 2025 |
|
| XTX Topco | 20k | $32k | 51% | Sep 2025 |
|
| Wells Fargo & Company | 20k | $32k | 259% | Sep 2025 |
|
| AQR Capital Management | 17k | $27k | -78% | Sep 2025 |
|
| UBS Group | 15k | $23k | -43% | Sep 2025 |
|
| Cetera Investment Advisers | 15k | $23k | 100% | Sep 2025 |
|
| H D Vest Advisory Services | 15k | $20k | 0% | Jun 2025 |
|
| Russell Investments | 13k | $21k | -3% | Sep 2025 |
|
| Intrepid Financial Planning Group | 13k | $20k | 0% | Sep 2025 |
|
| Point72 Asia | 10k | $17k | -51% | Sep 2025 |
|
| Level Four Advisory Services | 10k | $16k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 7.2k | $11k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 5.7k | $0 | 1% | Sep 2025 |
|
| Rockefeller Capital Management | 4.5k | $7.2k | 100% | Sep 2025 |
|
| Advisory Services Network | 2.5k | $3.9k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 2.2k | $3.5k | 8% | Sep 2025 |
|
| Federated Investors | 1.9k | $3.1k | -64% | Sep 2025 |
|
| Jpmorgan Chase & Co | 1.6k | $2.5k | -93% | Sep 2025 |
|
| CWM | 1.4k | $2.0k | -82% | Sep 2025 |
|
| NISA Investment Advisors | 958.00 | $1.5k | 0% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 855.00 | $1.4k | 0% | Sep 2025 |
|
| Tower Research Capital | 555.00 | $888.000000 | -78% | Sep 2025 |
|
| Group One Trading | 547.00 | $874.981200 | 0% | Sep 2025 |
|
| SBI Securities | 542.00 | $866.983200 | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 351.00 | $565.004700 | 17% | Sep 2025 |
|
| Pittenger & Anderson | 341.00 | $546.009200 | 0% | Sep 2025 |
|
| Groupe la Francaise | 316.00 | $435.985200 | 100% | Sep 2025 |
|
| Investors Research Corp | 300.00 | $480.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 237.00 | $379.010400 | -83% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 107.00 | $170.996700 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 86.00 | $138.004200 | -60% | Sep 2025 |
|
| SRS Capital Advisors | 34.00 | $53.998800 | 100% | Sep 2025 |
|
| Barclays | 4.00 | $8.000000 | -100% | Sep 2025 |
|
| True Wealth Design | 2.00 | $4.000000 | -92% | Sep 2025 |
|
| Cubist Systematic Strategies | 1.00 | $2.000000 | -100% | Sep 2025 |
|
Who sold out of Actinium Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Creative Financial Designs | Jun 2025 | 109k | $153k |
| Goldman Sachs Group | Mar 2025 | 77k | $124k |
| Y-Intercept | Jun 2025 | 65k | $91k |
| Jain Global | Jun 2025 | 31k | $43k |
| Am Investment Strategies | Jun 2025 | 31k | $43k |
| Hrt Financial | Jun 2025 | 28k | $38k |
| Catalyst Funds Management Pty | Jun 2025 | 15k | $20k |
| Schonfeld Strategic Advisors | Jun 2025 | 11k | $15k |
| Raymond James Financial | Jun 2025 | 1.2k | $1.6k |
| Hartland & Co | Jun 2025 | 306.00 | $429.012000 |